Biochemistry, Genetics and Molecular Biology
Hypoxia Inducible Factor 1
100%
Cancer Stem Cell
85%
Tretinoin
64%
Retinoic Acid
64%
Genetic Transcription
49%
Hypoxia-Inducible Factors
42%
Transcription
41%
Cancer Cell
36%
Histone
33%
CARD Domain
27%
Ubiquitination
25%
C-Terminus
25%
Interferon Production
25%
Sendai Virus
24%
RIG-I
23%
Citrullination
23%
B Cell
23%
RNA Virus
23%
TRAF3
21%
TRAF6
21%
CARD11
21%
WD40 Repeat
21%
TLR4
21%
Tumor Vascularization
21%
Plexin
21%
Guanosine Triphosphate
21%
Metalloproteinase
21%
T Cell Receptor
21%
TLR3
21%
Transcription Initiation
21%
S100A10
21%
Ubiquitin-Conjugating Enzyme
21%
Enzyme Activity
21%
Protein Kinases
21%
Histone Ubiquitination
21%
RNA Polymerase II
21%
Disintegrin
21%
Protein Repeat
21%
Response Element
19%
Epidermal Growth Factor Receptor
16%
KLF4
14%
SOX2
14%
Promoter Region
11%
Toll-Like Receptor
10%
Polymerase
10%
Lysine
9%
Stem Cell Self-Renewal
9%
Demethylase
8%
Tumor Initiation
8%
interferon
8%
Keyphrases
Hypoxia-inducible factor-1α (HIF-1α)
59%
Gene Transcription
45%
Breast Cancer Stem Cells
42%
Retinoic Acid-inducible Gene I (RIG-I)
42%
Antiviral Activity
25%
Adaptive Immunity
25%
Immune Checkpoint Blockade
25%
Nanog
24%
RING Finger Protein
23%
Melanoma Differentiation-associated Gene 5 (MDA5)
22%
E3 Ligase
21%
Anticancer Immunotherapy
21%
Anti-PD-1 Therapy
21%
Breast Cancer Invasion
21%
CARD11
21%
Metastatic Breast Cancer
21%
Chemotherapy-induced
21%
DNA-dependent Protein Kinase (DNA-PK)
21%
Hypoxia Response
21%
Novel E3 Ubiquitin Ligase
21%
S100A10
21%
KDM6A
21%
HIF Inhibitors
21%
Immunotherapy Efficacy
21%
Receptor-mediated
21%
Metalloprotease
21%
Anticancer Immunity
21%
Coactivator
21%
RNA Polymerase II (RNAPII)
21%
Independent Functions
21%
Plexin-B3
21%
TRIM28
21%
Facilitates Chromatin Transcription
21%
Hypoxia-inducible Factor
21%
Hepatocellular Carcinoma
21%
Dysregulated
21%
HTERT Gene
21%
Disintegrin
21%
Octamer-binding Transcription Factor 4 (OCT4)
21%
Tumor
14%
Natural Killer Cells
14%
CD8+ T Cells
14%
Pluripotency Factors
12%
Mouse Melanoma
10%
Polymerase II
10%
Hypoxia
10%
Knockdown
10%
Sendai Virus
9%
Annexin A2 (ANXA2)
9%
Chemotherapy
9%
Immunology and Microbiology
Sendai Virus
43%
Interferon Production
42%
interferon
37%
Mouse
32%
Adaptive Immune System
28%
RIG-I
28%
Immune Checkpoint Blockade
28%
Caspase Activation and Recruitment Domain
25%
Picornaviridae
21%
TLR3
21%
Carboxy Terminal Sequence
21%
Tumor Immunity
21%
WD Repeat
21%
Amino Terminal Sequence
21%
Cancer Immunotherapy
21%
Innate Immune System
21%
TLR4
21%
Viral Disease
17%
Natural Killer Cell
17%
Cytotoxic T-Cell
17%
Promoter Region
15%
Hypoxia Inducible Factor 1
14%
Gene Expression
14%
Inflammatory Cytokine
14%
RNA Interference
12%
IRF3
12%
RING Finger Motif
12%
Immunotherapy
12%
Immune Evasion
12%
Antiviral Activity
11%
Lymphocyte Activation
10%
RNA Virus
10%
Newcastle Disease Virus
10%
Cancer Cell
10%
DNA Virus
10%
Toll-Like Receptor
10%
Somatic Mutation
10%
Immunodeficiency
10%
Beta Interferon
10%
Vesiculovirus
9%
Tumor-Associated Macrophage
7%
Cancer Mortality
7%
Tumor Hypoxia
7%
Interleukin 1
7%
Immune Response
7%
Molecular Weight
7%
Myeloid-Derived Suppressor Cell
7%
Carcinoma Cell
7%
Protein Binding
7%
Body Weight
7%